Rhine biology lost 24.61 million last year

Last Saturday, the former Bull Stock Rhine bio (002166) disclosed its 2010 annual report Last year, the company realized a total operating revenue of 86.2995 million yuan, a decrease of 32.55% compared with the same period of 2009; realized a net profit of - 24.6106 million yuan, a decrease of 460.81% compared with the same period of 2009; and a loss of 0.19 yuan per share However, in the view of Rhine biology, this huge loss of net profit during the reporting period does not seem to be a bad thing Rhine Bio said that 2010 is the year of strategic adjustment Based on the long-term strategic consideration, the company gave up some varieties and customers with small sales volume and focused on the development of key products with good market prospects, while developing international large customers, especially large end customers However, due to the long cooperation cycle with key customers, the number of orders signed during the reporting period was reduced At the same time, due to the relocation of the company's office location, the company's expenses increased significantly compared with the previous year, resulting in a performance loss during the reporting period Rhine bio does not seem eager to improve its performance According to the announcement, the company plans to strive to achieve operating revenue of 130 million yuan and loss of no more than 12 million yuan in 2011 In view of the current macroeconomic uncertainty and the market development status of plant extracts, Rhine bio considers that there is a greater risk in making a clear expectation for the main business indicators in 2011.